This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit http://www.djreprints.com.
Updated Feb. 9, 2022 7:43 am ET / Original Feb. 9, 2022 7:19 am ET
- Order Reprints
- Print Article
CVS Health stock was falling after reporting better-than-expected earnings Wednesday but confirming full-year guidance that appeared to disappoint.
The company reported revenue of $76.6 billion for the fourth-quarter ending in December, up 10.1% compared with the prior year, beating the FactSet consensus of $75.6 billion. Adjusted earnings per share were $1.98, which topped the FactSet consensus of $1.83.